Peptide‐Fc Fusion Therapeutics: Applications and Challenges
- 12 February 2013
- book chapter
- Published by Wiley
- p. 123-142
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3Gastroenterology, 2010
- Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsClinical Immunology, 2009
- Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector FunctionsJournal of Molecular Biology, 2009
- RomiplostimDrugs, 2009
- Contemporary strategies for the stabilization of peptides in the α-helical conformationCurrent Opinion in Chemical Biology, 2008
- Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose HomeostasisDiabetes, 2008
- TeriparatideDrugs, 2008
- Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activationProceedings of the National Academy of Sciences, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Protein aggregation and bioprocessingThe AAPS Journal, 2006